logo
welcome
Reuters

Reuters

EU top court backs Illumina fight against EU probe into Grail deal

Reuters
Summary
Nutrition label

79% Informative

Europe 's top court backs U.S. gene sequencing company Illumina 's fight against EU antitrust regulators' investigation into its $7.1 billion bid for cancer diagnostic test maker Grail .

The General Court had in 2022 ruled in favour of the European Commission .

Illumina founded Grail and spun it off in 2016 only to re-acquire it in 2021 .

VR Score

90

Informative language

98

Neutral language

45

Article tone

formal

Language

English

Language complexity

58

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links